Keyphrases
6-month Follow-up
33%
Acute Rejection
22%
Age-associated B Cells
6%
Aging
33%
Aging Cell
6%
Antibody Titer
9%
Antigen Retention
8%
B Cell Subsets
12%
B Cells
20%
Biological Characteristics
33%
CD28
20%
Cell Subsets
6%
Cell-Associated
6%
Cellular Immune Response
53%
Cellular Response
34%
COVID-19 Vaccination
33%
Cytomegalovirus
6%
Elderly Donor
6%
H7N9 Vaccine
16%
H7N9 Virus
33%
Herpes Zoster Vaccine
13%
High Risk
6%
Human Leukocyte antigen-G (HLA-G)
33%
Humoral Immune Response
40%
Humoral Response
25%
Immune Response
33%
Immune System
33%
Immune Tolerance
9%
Immunogenicity
11%
Live-attenuated Herpes Zoster Vaccine
33%
Lung Transplantation
100%
Material Solutions
8%
Merck
6%
MRNA-1273
15%
Neutralizing Antibodies
9%
One Dose
6%
Pathological Section
8%
Peripheral Blood
6%
Pretransplant
9%
Response to Vaccination
6%
Seropositivity
6%
Solid Organ Transplantation
33%
T Cell Response
24%
T Cell Subsets
12%
T Cells
24%
Transplant Recipients
6%
Vaccination
90%
Waiting List
33%
Young Person
6%
Zostavax
13%
Immunology and Microbiology
Acute Graft Rejection
22%
Adoptive Immunity
45%
Antibody Titer
11%
B Cell
16%
B Lymphocyte Subpopulation
9%
CD28
12%
Chemokine
5%
COVID-19
33%
Gene Expression
5%
Herpes Zoster
12%
Human Leukocyte Antigen
33%
Humoral Immunity
37%
Immune Response
33%
Immune System
33%
Immune Tolerance
9%
Immunogenicity
11%
Immunoglobulin G Antibody
5%
Immunosuppression
5%
Immunosuppressive Drug
5%
Interferon Gamma
11%
Lung Transplantation
100%
Monospecific Antibody
11%
Neutralizing Antibody
11%
Severe Acute Respiratory Syndrome Coronavirus 2
11%
Solid Organ Transplantation
33%
Spike
5%
T Cell
45%
T Cell Subset
9%
Vaccination Policy
100%
Vaccine Efficacy
11%
Zoster Vaccine
33%
Medicine and Dentistry
Acute Graft Rejection
22%
B Cell
33%
B Lymphocyte Subpopulation
13%
Biological Marker
11%
Biomarker Study
5%
Cellular Immunity
58%
Chemokine
5%
COVID-19 Vaccination
33%
Cytomegalovirus
8%
Disseminated Herpes Zoster
25%
Gamma Interferon
5%
Gene Expression
5%
Gene Linkage
5%
Humoral Immunity
41%
Immune Response
33%
Immune System
33%
Immunogenicity
11%
Immunoglobulin G Antibody
5%
Immunosuppressive Treatment
11%
Infection
11%
Interferon Gamma Release Assay
5%
Lung Transplantation
100%
Neutralizing Antibody
11%
Severe Acute Respiratory Syndrome Coronavirus 2
11%
T Cell
30%
T Cell Subset
13%
T-Cell Response
27%
Transplantation
8%
Varicella Zoster Vaccine
33%
